Contact this trialFirst, we need to learn more about you.
mTOR inhibitor
Vorinostat + Temsirolimus for Brain Tumors
Recruiting1 awardPhase 1
Houston, Texas
This trial is studying the side effects and best dose of temsirolimus when given with vorinostat and with or without radiation therapy in treating younger patients with newly diagnosed or progressive diffuse intrinsic pontine glioma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.